COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Treatment Intensification With Temozolomide in Adults With a Glioblastoma (StrateGlio)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03663725
Recruitment Status : Recruiting
First Posted : September 10, 2018
Last Update Posted : May 15, 2019
Association de Neuro-Oncologues d'Expression Francaise
Erasme University Hospital
Information provided by (Responsible Party):
Centre Oscar Lambret

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 1, 2022
Estimated Study Completion Date : May 1, 2023